Приказ основних података о документу
Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis
dc.creator | Bass, Edward J. | |
dc.creator | Pantović, Ana | |
dc.creator | Connor, Martin J. | |
dc.creator | Loeb, Stacy | |
dc.creator | Rastinehad, Ardeshir R. | |
dc.creator | Winkler, Mathias H. | |
dc.creator | Gabe, Rhian | |
dc.creator | Ahmed, Hashim U. | |
dc.date.accessioned | 2021-10-25T10:24:17Z | |
dc.date.available | 2021-10-25T10:24:17Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1365-7852 | |
dc.identifier.uri | http://rimi.imi.bg.ac.rs/handle/123456789/1169 | |
dc.description.abstract | Background: Multiparametric MRI localizes cancer in the prostate, allowing for MRI guided biopsy (MRI-GB) 43 alongside transrectal ultrasound-guided systematic biopsy (TRUS-GB). Three MRI-GB approaches exist; visual estimation (COG-TB); fusion software-assisted (FUS-TB) and MRI ‘in-bore’ biopsy (IB-TB). It is unknown whether any of these are superior. We conducted a systematic review and meta-analysis to address three questions. First, whether MRI-GB is superior to TRUS-GB at detecting clinically significant PCa (csPCa). Second, whether MRI-GB is superior to TRUS-GB at avoiding detection of insignificant PCa. Third, whether any MRI-GB strategy is superior at detecting csPCa. Methods: A systematic literature review from 2015 to 2019 was performed in accordance with the START recommendations. Studies reporting PCa detection rates, employing MRI-GB and TRUS-GB were included and evaluated using the QUADAS-2 checklist. 1553 studies were found, of which 43 were included in the meta-analysis. Results: For csPCa, MRI-GB was superior in detection to TRUS-GB (0.83 vs. 0.63 [p = 0.02]). MRI-GB was superior in detection to TRUS-GB at avoiding detection of insignificant PCa. No MRI-GB technique was superior at detecting csPCa (IB-TB 0.87; COG TB 0.81; FUS-TB 0.81, [p = 0.55]). There was significant heterogeneity observed between the included studies. Conclusions: In patients with suspected PCa on MRI, MRI-GB offers superior rates of csPCa detection and reduces detection of insignificant PCa compared to TRUS-GB. No individual MRI-GB technique was found to be better in csPCa detection. Prospective adequately powered randomized controlled trials are required. | |
dc.publisher | Springer Nature | |
dc.relation | HA is supported by the Wellcome Trust via a Senior Clinical Research Fellowship. Grant code: 204998/Z/16/Z | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Prostate Cancer and Prostatic Diseases | |
dc.title | Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis | |
dc.type | article | |
dc.rights.license | BY | |
dc.citation.epage | 179 | |
dc.citation.issue | 2 | |
dc.citation.spage | 174 | |
dc.citation.volume | 25 | |
dc.identifier.doi | 10.1038/s41391-021-00449-7 | |
dc.identifier.fulltext | http://rimi.imi.bg.ac.rs/bitstream/id/2517/Diagnostic_accuracy_of_magnetic_resonance_pub_2021.pdf | |
dc.type.version | publishedVersion |